Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr₹-189 Cr

What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS is ₹-814 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-814 Cr
Mar2024₹-164 Cr
Mar2023₹-145 Cr
Mar2022₹-152 Cr
Mar2021₹-189 Cr

How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-814 Cr
Negative
Mar2024 ₹-164 Cr
Negative
Mar2023 ₹-145 Cr
Negative
Mar2022 ₹-152 Cr
Negative
Mar2021 ₹-189 Cr -

Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹28,626.8 Cr -3.3% 1.4% 54.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-3.3%

1.4%

54.3%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses